Ed Brennan has spent his career as a scientist, entrepreneur and venture capitalist. He has participated in the development, management and financing of new medical technology ventures for over 30 years, including scientific and executive positions with Syntex, UroSystems, Medtronic, DepoMed Systems and CardioGenesis.
Prior to joining TauTona Group, Ed was Chief Executive Officer of Nexus Dx, a medical diagnostics company located in San Diego, California. Nexus was acquired by Samsung Electronics from ITC Nexus Holding Company, where Ed had been Chief Integration Officer following the merger of Nexus Dx and International Technidyne Corporation. Previously, he was President and Chief Operating Officer of CryoCor until June 2008, when the company was sold to Boston Scientific Corporation. He also served as chairman of HemoSense until its sale to Inverness Medical Innovations in November 2007. Ed was a Managing Partner of Perennial Ventures, a Seattle-based venture capital firm and Vice President at Tredegar Investments.
Ed currently serves on multiple boards including Kilroy Real Estate, where he was been a member since July 2003 and Lead Independent Director since March 2014. He is also on the board of directors of several private companies and previously served on the Board of Trustees of Goucher College, Baltimore, Maryland.
Ed holds B.A. degrees in chemistry and biology and a Ph.D. in biology from the University of California, Santa Cruz.
604 Fifth Avenue, Suite D, Redwood City, CA 94063 Phone +1 (650) 503-8250